Company ResMed Inc. Australian S.E.

Equities

RMD

AU000000RMD6

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for ResMed Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Delayed Australian S.E. Other stock markets 01:22:32 2024-04-19 am EDT			5-day change	1st Jan Change
27.91 ^AUD	+1.01%		-4.42%	+9.71%

Apr. 17	Wall St set for higher open on megacaps boost; earnings, Fed comments on tap	RE
Apr. 01	Needham Adjusts ResMed's Price Target to $224 From $180, Maintains Buy Rating	MT

ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:

- medical devices (50.4%);

- masks (37.9%);

- software as a service (11.7%).

At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.

The United States accounts for 61.4% of net sales.

Number of employees: 10,140

USD in Million	2022	Weight	2023	Weight	Delta
Sleep and Respiratory Care 88.2 %	3,177	88.8 %	3,725	88.2 %	+17.24%
Software as a Service 11.8 %	401	11.2 %	498	11.8 %	+24.24%

USD in Million	2022	Weight	2023	Weight	Delta
United States 64.4 %	2,249	62.9 %	2,720	64.4 %	+20.92%
Europe, Asia, and Other Markets 29.4 %	1,195	33.4 %	1,242	29.4 %	+3.86%
Rest of the World 6.2 %	0	0.0 %	261	6.2 %	-

Managers	Title	Age	Since
Mick Farrell CEO	Chief Executive Officer	51	00-08-31
Peter Farrell FOU	Founder	81	89-05-31
Brett Sandercock DFI	Director of Finance/CFO	57	97-12-31
Jim Ellis CMP	Compliance Officer	-	-
Carlos Nunez CTO	Chief Tech/Sci/R&D Officer	-	17-01-02
Amy Wakeham IRC	Investor Relations Contact	-	18-05-31
Hemanth Reddy PRN	Corporate Officer/Principal	-	13-08-31
Todd Friedman PRN	Corporate Officer/Principal	-	-
Michael Fliss PRN	Corporate Officer/Principal	-	-
Michael Rider LAW	General Counsel	-	11-12-31

Members of the board	Title	Age	Since
Mick Farrell CEO	Chief Executive Officer	51	00-08-31
Ron Taylor BRD	Director/Board Member	76	04-12-31
Peter Farrell FOU	Founder	81	89-05-31
Rich Sulpizio BRD	Director/Board Member	74	05-08-24
Karen Drexler BRD	Director/Board Member	64	17-11-16
Jan de Witte BRD	Director/Board Member	59	19-05-15
Carol Burt BRD	Director/Board Member	66	13-10-31
Harjit Gill BRD	Director/Board Member	59	18-11-14
John Hernandez BRD	Director/Board Member	57	21-11-17
Desney Tan BRD	Director/Board Member	48	21-11-17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	189,260,596	145,884,503 ( 77.08 %)	42,171,708 ( 22.28 %)	77.08 %

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 12.06 %	17,743,457	12.06 %	3 514 M $
BlackRock Advisors LLC 6.940 %	10,207,358	6.940 %	2 021 M $
STATE STREET CORPORATION 4.276 %	6,290,089	4.276 %	1 246 M $
Geode Capital Management LLC 2.336 %	3,435,280	2.336 %	680 M $
Fidelity Management & Research Co. LLC 1.715 %	2,523,104	1.715 %	500 M $
Invesco Advisers, Inc. 1.324 %	1,947,175	1.324 %	386 M $
Eaton Vance Management 1.186 %	1,744,028	1.186 %	345 M $
BlackRock Life Ltd. 1.184 %	1,741,086	1.184 %	345 M $
MIV Asset Management AG 1.062 %	1,562,000	1.062 %	309 M $
Norges Bank (13F) 0.9247 %	1,360,110	0.9247 %	269 M $

Name	Equities	%	Valuation
Australian Foundation Investment Co. Ltd. (Invt Mgmt) 0.2985 %	4,390,002	0.2985 %	86 M $
BetaShares Capital Ltd. 0.2165 %	3,183,983	0.2165 %	63 M $
BNP PARIBAS ASSET MANAGEMENT Netherlands NV 0.1115 %	1,640,216	0.1115 %	32 M $
Russell Investment Management Ltd. 0.0968 %	1,423,718	0.0968 %	28 M $
Sjunde AP-fonden 0.0623 %	916,060	0.0623 %	18 M $
Australian United Investment Co. Ltd. (Investment Management) 0.0510 %	750,000	0.0510 %	15 M $
National Treasury Management Agency (Invt Mgmt) 0.0507 %	745,508	0.0507 %	15 M $
Yarra Investment Management Ltd. 0.0455 %	669,834	0.0455 %	13 M $
Paradice Investment Management Pty Ltd. 0.0442 %	650,325	0.0442 %	13 M $
Diversified United Investment Ltd. (Investment Management) 0.0340 %	500,000	0.0340 %	10 M $

Name	Equities	%	Valuation
NYXOAH SA 5.65%	1,619,756	5.65%	21,516,839 $

ResMed, Inc.

9001 Spectrum Center Boulevard

92123, San Diego

+858-836-5000

http://www.resmed.com

Name	Category and Sector
ResMed India Pvt Ltd. ResMed India Pvt Ltd. Medical/Nursing ServicesHealth Services Part of ResMed, Inc., ResMed India Pvt Ltd. is an Indian company that manufactures medical equipment. The private company is based in Noida, India and was founded in 2007.	Medical/Nursing Services

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

173.8 USD

Average target price

206.1 USD

Spread / Average Target

+18.54%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+2.02%	209B
DANAHER CORPORATION	+2.17%	177B
INTUITIVE SURGICAL, INC.	+10.45%	133B
BOSTON SCIENTIFIC CORPORATION	+16.62%	99.89B
SIEMENS HEALTHINEERS AG	-2.70%	61.83B
EDWARDS LIFESCIENCES CORPORATION	+13.38%	52.51B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.33%	45.54B
AGILENT TECHNOLOGIES, INC.	-4.74%	39.43B
GE HEALTHCARE TECHNOLOGIES INC.	+9.89%	38.87B

Other Advanced Medical Equipment & Technology